On the upside
Bargain hunters snapped up shares of XenoPort (Nasdaq: XNPT), whose stock price dropped yesterday after the Food and Drug Administration failed to approve the company's restless leg syndrome treatment Horizant.
KeyBanc Capital Markets upgraded Liz Claiborne (NYSE: LIZ) to a Buy rating.
Fourth quarter earnings and revenue for Newpark Resources (NYSE: NR) beat analyst expectations.
On the downside
Merit Medical Systems (Nasdaq: MMSI) reported lower fourth quarter earnings.
The Knot (Nasdaq: KNOT) blamed impairment charges for widening fourth quarter losses.
Endologix (Nasdaq: ELGX) reported a loss for the fourth quarter.
In the broad market, advancing issues outpaced decliners by a margin of 7 to 5 on the NYSE and by 10 to 9 on Nasdaq. The Russell 2000 which tracks small cap stocks gained 2 points to 631.